Skip to main content

Smoking Cessation, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.

Publication ,  Journal Article
Shields, PG; Bierut, L; Arenberg, D; Balis, D; Cinciripini, PM; Davis, J; Edmondson, D; Feliciano, J; Hitsman, B; Hudmon, KS; Jaklitsch, MT ...
Published in: J Natl Compr Canc Netw
March 2023

Although the harmful effects of smoking after a cancer diagnosis have been clearly demonstrated, many patients continue to smoke cigarettes during treatment and beyond. The NCCN Guidelines for Smoking Cessation emphasize the importance of smoking cessation in all patients with cancer and seek to establish evidence-based recommendations tailored to the unique needs and concerns of patients with cancer. The recommendations contained herein describe interventions for cessation of all combustible tobacco products (eg, cigarettes, cigars, hookah), including smokeless tobacco products. However, recommendations are based on studies of cigarette smoking. The NCCN Smoking Cessation Panel recommends that treatment plans for all patients with cancer who smoke include the following 3 tenets that should be done concurrently: (1) evidence-based motivational strategies and behavior therapy (counseling), which can be brief; (2) evidence-based pharmacotherapy; and (3) close follow-up with retreatment as needed.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

March 2023

Volume

21

Issue

3

Start / End Page

297 / 322

Location

United States

Related Subject Headings

  • Tobacco Products
  • Smoking Cessation
  • Smoking
  • Oncology & Carcinogenesis
  • Neoplasms
  • Medical Oncology
  • Humans
  • 4203 Health services and systems
  • 3211 Oncology and carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Shields, P. G., Bierut, L., Arenberg, D., Balis, D., Cinciripini, P. M., Davis, J., … Darlow, S. (2023). Smoking Cessation, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 21(3), 297–322. https://doi.org/10.6004/jnccn.2023.0013
Shields, Peter G., Laura Bierut, Douglas Arenberg, David Balis, Paul M. Cinciripini, James Davis, Donna Edmondson, et al. “Smoking Cessation, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw 21, no. 3 (March 2023): 297–322. https://doi.org/10.6004/jnccn.2023.0013.
Shields PG, Bierut L, Arenberg D, Balis D, Cinciripini PM, Davis J, et al. Smoking Cessation, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2023 Mar;21(3):297–322.
Shields, Peter G., et al. “Smoking Cessation, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw, vol. 21, no. 3, Mar. 2023, pp. 297–322. Pubmed, doi:10.6004/jnccn.2023.0013.
Shields PG, Bierut L, Arenberg D, Balis D, Cinciripini PM, Davis J, Edmondson D, Feliciano J, Hitsman B, Hudmon KS, Jaklitsch MT, Leone FT, Ling P, McCarthy DE, Ong MK, Park ER, Prochaska J, Sandoval AJ, Sheffer CE, Spencer S, Studts JL, Tanvetyanon T, Tindle HA, Tong E, Triplette M, Urbanic J, Videtic G, Warner D, Whitlock CW, McCullough B, Darlow S. Smoking Cessation, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2023 Mar;21(3):297–322.

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

March 2023

Volume

21

Issue

3

Start / End Page

297 / 322

Location

United States

Related Subject Headings

  • Tobacco Products
  • Smoking Cessation
  • Smoking
  • Oncology & Carcinogenesis
  • Neoplasms
  • Medical Oncology
  • Humans
  • 4203 Health services and systems
  • 3211 Oncology and carcinogenesis